Bayer Global - Home | Bayer Global
Bayer. At Bayer, innovations in health and agriculture are at the core of what we do. We develop solutions that improve lives and protect...
Read Bayer.com news digest here: view the latest Bayer articles and content updates right away or get to their most visited pages. Bayer.com is currently one of the largest websites, with more than 828K visitors from all over the world monthly. It seems that Bayer content is notably popular in India, as 20.4% of all users (169K visits per month) come from this country. We haven’t detected security issues or inappropriate content on Bayer.com and thus you can safely use it. Bayer.com is hosted with Akamai Technologies, Inc. (United States) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
27 614
Visitors daily -
55 230
Pageviews daily -
7
Google PR -
2 056
Alexa rank
Best pages on Bayer.com
-
Bayer Global - Home | Bayer Global
At Bayer, innovations in health and agriculture are at the core of what we do. We develop solutions that improve lives and protect the planet.
-
Results from PULSAR demonstrate long term efficacy of aflibercept 8 mg with extended dosing intervals reaching up to 24 weeks and vision improvements comparable to Eylea™ (aflibercept 2 mg) at fixed 8...
-
Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator
Investigational VVD-130037 is highly specific, potent Kelch-like ECH Associated Protein 1 (KEAP1) activator developed for treatment of advanced solid tumors / Major milestone for Vividion’s chemoprote...
Bayer.com news digest
-
2 years
OCEANIC-AF study stopped early due to lack of efficacy
Berlin, November 19, 2023 – OCEANIC-AF, a phase III study investigating asundexian compared to apixaban (a direct oral anticoagulant) in patients with atrial fibrillation at risk for stroke is being stopped early. This decision is based on the recommendation...
-
2 years
Third quarter below prior year as expected – Group outlook confirmed
Leverkusen, November 8, 2023 – Bayer has confirmed its Group outlook for 2023 after posting third-quarter figures that were down against the previous year. “The results came in largely as we expected, knowing that Q3 is never our strongest quarter. The...
-
2 years
Bayer introduces agricultural system for direct-seeded rice with potential to re...
Manila, Philippines, October 16, 2023 – On UN World Food Day, Bayer announced the introduction of its direct-seeded rice (DSR) system at the 6th International Rice Congress in Manila. Moving from transplanted puddled rice cultivation to direct-seeded...
-
2 years
Bayer to partner with Twist Bioscience to accelerate drug discovery
Berlin, October 5, 2023 – Bayer AG has entered into an antibody discovery, option, and license agreement with Twist Bioscience Corporation, a company offering high-quality synthetic DNA using its silicon platform.
The company’s “Library of Libraries”, a collection of synthetic antibody libraries that harness innovative structural and developability features to cover a wide range of antibody drug targets, is tailored to address specific challenges in antibody discovery...
Domain history
| Web host: | Akamai Technologies, Inc. |
| Registrar: | CSC Corporate Domains, Inc. |
| Registrant: | Domain Administrator (Bayer AG) |
| Updated: | January 22, 2025 |
| Expires: | January 26, 2027 |
| Created: | January 25, 1996 |
Whois record
Visitor gender
Male
Female
Safety scores
Trustworthiness
ExcellentChild safety
N/A
